Clinical Trial

Rehabilitation of Airway Protection in Parkinson's Disease

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Airway protective disorders are a prevalent and progressive consequence of Parkinson's Disease (PD), and often result in aspiration pneumonia which is the leading cause of death in PD. Despite this, a large number of patients with PD do not access specialized services to address these critical deficits. The investigators will examine the comparative effectiveness of a novel treatment paradigm delivered in-person versus via telehealth in persons with PD, as well as the role of patient burden and treatment adherence on outcomes; thus, the proposed research is relevant to public health and in line with NIH's mission to identify novel, efficacious, and accessible rehabilitation strategies for short- and long-term improvement of dysfunctional airway protection in PD.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-01-17; most recent amendment 2025-09-19.
Status change: Active, Not Recruiting → Recruiting 2024-04-09
Trial Details
NCT Number NCT05700825
Lead Sponsor Teachers College, Columbia University
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS), Purdue University
Conditions Parkinson Disease, Dysphagia
Enrollment 120 participants
Start Date 2022-08-11
Primary Completion 2027-09-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-24